Completed enrollment for the Artificial Meniscus, a “game-changer” for early OA

By

ACTIVE IMPLANTS WRAPS UP NUSURFACE TRIAL ENROLLMENT (Orthopedics This Week)
Memphis, Tennessee-based Active Implants LLC has announced that the final patient has been treated in the two clinical trials evaluating its NUsurface Meniscus Implant for the treatment of persistent knee pain caused by injured or deteriorated meniscus tissue.
The trials are being conducted as part of the process to obtain U.S. Food and Drug Administration (FDA) De Novo 510(k) clearance. If approved, says the company, the NUsurface Implant would be the first “artificial meniscus.”
“We are now one step closer to filli...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.